Review article · 2026
PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy
Drug Discovery Today, 31(6), 104844 · Published 22 October 2026 · DOI 10.1016/j.drudis.2026.104844
In brief
“PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy” is a 2026 review article by Eman M Elkafoury and 5 co-authors, published in Drug Discovery Today. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 60
- Authors
- 6
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Elkafoury, E. M., El-Moselhy, T. F., El‐Hamamsy, M. H., El-Bastawissy, E. A., Sidhom, P. A., & Abulkhair, H. S. (2026). PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy. Drug Discovery Today, 31(6), 104844. https://doi.org/10.1016/j.drudis.2026.104844
MLA 9
Elkafoury, Eman M, et al. “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy.” Drug Discovery Today, vol. 31, no. 6, 2026, p. 104844. https://doi.org/10.1016/j.drudis.2026.104844.
Chicago
Elkafoury, Eman M, Tarek Fathy El-Moselhy, Mervat H. El‐Hamamsy, Eman A. El-Bastawissy, Peter A. Sidhom, and Hamada S. Abulkhair. 2026. “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy.” Drug Discovery Today 31 (6): 104844. https://doi.org/10.1016/j.drudis.2026.104844.
Harvard
Elkafoury, E. M. et al. (2026) ‘PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy’, Drug Discovery Today, 31(6), p. 104844. doi:10.1016/j.drudis.2026.104844.
IEEE
E. M. Elkafoury, T. F. El-Moselhy, M. H. El‐Hamamsy, E. A. El-Bastawissy, P. A. Sidhom, and H. S. Abulkhair, “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy,” Drug Discovery Today, vol. 31, no. 6, p. 104844, 2026, doi: 10.1016/j.drudis.2026.104844.
BibTeX
@article{elkafoury2026parp,
title = {{PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy}},
author = {Elkafoury, Eman M and El-Moselhy, Tarek Fathy and El‐Hamamsy, Mervat H. and El-Bastawissy, Eman A. and Sidhom, Peter A. and Abulkhair, Hamada S.},
journal = {Drug Discovery Today},
year = {2026},
volume = {31},
number = {6},
pages = {104844},
doi = {10.1016/j.drudis.2026.104844},
url = {https://doi.org/10.1016/j.drudis.2026.104844}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP-1 inhibitors
- PARP2
- homologous recombination deficiency
- poly(ADP-ribosyl)ation
- PARP trapping
- hematologic toxicity
- therapeutic index
- bone marrow recovery
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Elkafoury, E. M., El-Moselhy, T. F., El‐Hamamsy, M. H., El-Bastawissy, E. A., Sidhom, P. A., & Abulkhair, H. S. (2026). PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy. Drug Discovery Today, 31(6), 104844. https://doi.org/10.1016/j.drudis.2026.104844
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Eman M Elkafoury, Tarek Fathy El-Moselhy, Mervat H. El‐Hamamsy, Eman A. El-Bastawissy, Peter A. Sidhom, Hamada S. Abulkhair.
What is the DOI of this paper?
10.1016/j.drudis.2026.104844, permanently at https://doi.org/10.1016/j.drudis.2026.104844. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.